International Clinical Trial: ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography

Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06676280) titled 'ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography' on Nov. 4, 2024.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Factorial Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: Jung-min Ahn

Condition: Cardiovascular Diseases

Intervention: Drug: Aspirin Drug: High-intensity statin

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: April 28, 2025

Target Sample Size: 5000

To know more, visit https://clinicaltrials.gov/ct2/show/NCT06676280

Published b...